SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (160)8/17/1999 12:53:00 AM
From: Pseudo Biologist   of 427
 
Thanks, as I stated originally, the idea was to play "devil's advocate" with nice/nasty one-liners.

I do have a holding in CELG, but have been too chicken to go into TKTX. I do think it is the "gorilla-game way" to play gene therapy, if one must.

With CELG the key may be filings of sNDA's as they start getting harder data on Crohn's and some cancers. As you say, with STEPS it is hard to grow the market. Still, they may be just one or two quarters behind "aggressive" expectations I saw a year or so ago. Not bad at all if you ask me.

PB

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News